These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 15947797

  • 1. Age-related macular degeneration: economic burden and value-based medicine analysis.
    Brown MM, Brown GC, Stein JD, Roth Z, Campanella J, Beauchamp GR.
    Can J Ophthalmol; 2005 Jun; 40(3):277-87. PubMed ID: 15947797
    [Abstract] [Full Text] [Related]

  • 2. The burden of age-related macular degeneration: a value-based medicine analysis.
    Brown GC, Brown MM, Sharma S, Stein JD, Roth Z, Campanella J, Beauchamp GR.
    Trans Am Ophthalmol Soc; 2005 Jun; 103():173-84; discussion 184-6. PubMed ID: 17057801
    [Abstract] [Full Text] [Related]

  • 3. The burden of age-related macular degeneration: a value-based analysis.
    Brown MM, Brown GC, Sharma S, Stein JD, Roth Z, Campanella J, Beauchamp GR.
    Curr Opin Ophthalmol; 2006 Jun; 17(3):257-66. PubMed ID: 16794438
    [Abstract] [Full Text] [Related]

  • 4. Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study.
    Cruess AF, Zlateva G, Xu X, Soubrane G, Pauleikhoff D, Lotery A, Mones J, Buggage R, Schaefer C, Knight T, Goss TF.
    Pharmacoeconomics; 2008 Jun; 26(1):57-73. PubMed ID: 18088159
    [Abstract] [Full Text] [Related]

  • 5. Burden of illness of neovascular age-related macular degeneration in Canada.
    Cruess A, Zlateva G, Xu X, Rochon S.
    Can J Ophthalmol; 2007 Dec; 42(6):836-43. PubMed ID: 18026200
    [Abstract] [Full Text] [Related]

  • 6. Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999.
    Coleman AL, Yu F.
    Ophthalmology; 2008 Jan; 115(1):18-25. PubMed ID: 17572499
    [Abstract] [Full Text] [Related]

  • 7. [Age-related macular degeneration: a socioeconomic time bomb in our aging society].
    Schrader WF.
    Ophthalmologe; 2006 Sep; 103(9):742-8. PubMed ID: 16924447
    [Abstract] [Full Text] [Related]

  • 8. The treatment of wet AMD in Canada: access to therapy (policy review).
    Cruess A, Maberley D, Wong D, Chen J.
    Can J Ophthalmol; 2009 Oct; 44(5):548-56. PubMed ID: 19789590
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Age-related macular degeneration – a challenge for public health care].
    Mantel I.
    Ther Umsch; 2016 Oct; 73(2):79-83. PubMed ID: 26982646
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Patterns and costs associated with progression of age-related macular degeneration.
    Schmier JK, Covert DW, Lau EC.
    Am J Ophthalmol; 2012 Oct; 154(4):675-681.e1. PubMed ID: 22835513
    [Abstract] [Full Text] [Related]

  • 19. Comparative effectiveness and cost-effectiveness of the implantable miniature telescope.
    Brown GC, Brown MM, Lieske HB, Lieske PA, Brown KS, Lane SS.
    Ophthalmology; 2011 Sep; 118(9):1834-43. PubMed ID: 21723614
    [Abstract] [Full Text] [Related]

  • 20. The cost-effectiveness of treatment of age-related macular degeneration: a review.
    Kymes Steven M.
    Minerva Med; 2009 Feb; 100(1):69-78. PubMed ID: 19277005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.